244 related articles for article (PubMed ID: 8764091)
21. Membrane targeting properties of a herpesvirus tegument protein-retrovirus Gag chimera.
Bowzard JB; Visalli RJ; Wilson CB; Loomis JS; Callahan EM; Courtney RJ; Wills JW
J Virol; 2000 Sep; 74(18):8692-9. PubMed ID: 10954570
[TBL] [Abstract][Full Text] [Related]
22. Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein.
Parent LJ; Wilson CB; Resh MD; Wills JW
J Virol; 1996 Feb; 70(2):1016-26. PubMed ID: 8551559
[TBL] [Abstract][Full Text] [Related]
23. Incorporation of chimeric gag protein into retroviral particles.
Weldon RA; Erdie CR; Oliver MG; Wills JW
J Virol; 1990 Sep; 64(9):4169-79. PubMed ID: 2166812
[TBL] [Abstract][Full Text] [Related]
24. Characterization of Rous sarcoma virus Gag particles assembled in vitro.
Yu F; Joshi SM; Ma YM; Kingston RL; Simon MN; Vogt VM
J Virol; 2001 Mar; 75(6):2753-64. PubMed ID: 11222698
[TBL] [Abstract][Full Text] [Related]
25. The membrane-binding domain of the Rous sarcoma virus Gag protein.
Verderame MF; Nelle TD; Wills JW
J Virol; 1996 Apr; 70(4):2664-8. PubMed ID: 8642704
[TBL] [Abstract][Full Text] [Related]
26. Overlapping roles of the Rous sarcoma virus Gag p10 domain in nuclear export and virion core morphology.
Scheifele LZ; Kenney SP; Cairns TM; Craven RC; Parent LJ
J Virol; 2007 Oct; 81(19):10718-28. PubMed ID: 17634229
[TBL] [Abstract][Full Text] [Related]
27. In vivo interference of Rous sarcoma virus budding by cis expression of a WW domain.
Patnaik A; Wills JW
J Virol; 2002 Mar; 76(6):2789-95. PubMed ID: 11861846
[TBL] [Abstract][Full Text] [Related]
28. RNA dimerization defect in a Rous sarcoma virus matrix mutant.
Parent LJ; Cairns TM; Albert JA; Wilson CB; Wills JW; Craven RC
J Virol; 2000 Jan; 74(1):164-72. PubMed ID: 10590103
[TBL] [Abstract][Full Text] [Related]
29. Deletion of a Cys-His motif from the Alpharetrovirus nucleocapsid domain reveals late domain mutant-like budding defects.
Lee EG; Linial ML
Virology; 2006 Mar; 347(1):226-33. PubMed ID: 16406458
[TBL] [Abstract][Full Text] [Related]
30. Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.
Dettenhofer M; Yu XF
J Virol; 1999 Jun; 73(6):4696-704. PubMed ID: 10233929
[TBL] [Abstract][Full Text] [Related]
31. Transport and processing of the Rous sarcoma virus Gag protein in the endoplasmic reticulum.
Krishna NK; Weldon RA; Wills JW
J Virol; 1996 Mar; 70(3):1570-9. PubMed ID: 8627676
[TBL] [Abstract][Full Text] [Related]
32. The gag domains required for avian retroviral RNA encapsidation determined by using two independent assays.
Lee Eg; Yeo A; Kraemer B; Wickens M; Linial ML
J Virol; 1999 Aug; 73(8):6282-92. PubMed ID: 10400719
[TBL] [Abstract][Full Text] [Related]
33. Insertion of a classical nuclear import signal into the matrix domain of the Rous sarcoma virus Gag protein interferes with virus replication.
Garbitt RA; Bone KR; Parent LJ
J Virol; 2004 Dec; 78(24):13534-42. PubMed ID: 15564464
[TBL] [Abstract][Full Text] [Related]
34. Genetic analysis of interactions between Gag proteins of Rous sarcoma virus.
Li X; Yuan B; Goff SP
J Virol; 1997 Jul; 71(7):5624-30. PubMed ID: 9188638
[TBL] [Abstract][Full Text] [Related]
35. Nuclear entry and CRM1-dependent nuclear export of the Rous sarcoma virus Gag polyprotein.
Scheifele LZ; Garbitt RA; Rhoads JD; Parent LJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3944-9. PubMed ID: 11891341
[TBL] [Abstract][Full Text] [Related]
36. The C-terminal half of TSG101 blocks Rous sarcoma virus budding and sequesters Gag into unique nonendosomal structures.
Johnson MC; Spidel JL; Ako-Adjei D; Wills JW; Vogt VM
J Virol; 2005 Mar; 79(6):3775-86. PubMed ID: 15731271
[TBL] [Abstract][Full Text] [Related]
37. Efficient particle production by minimal Gag constructs which retain the carboxy-terminal domain of human immunodeficiency virus type 1 capsid-p2 and a late assembly domain.
Accola MA; Strack B; Göttlinger HG
J Virol; 2000 Jun; 74(12):5395-402. PubMed ID: 10823843
[TBL] [Abstract][Full Text] [Related]
38. Identification of retroviral late domains as determinants of particle size.
Garnier L; Parent LJ; Rovinski B; Cao SX; Wills JW
J Virol; 1999 Mar; 73(3):2309-20. PubMed ID: 9971814
[TBL] [Abstract][Full Text] [Related]
39. Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.
Ott DE; Coren LV; Gagliardi TD; Nagashima K
J Virol; 2005 Jul; 79(14):9038-45. PubMed ID: 15994797
[TBL] [Abstract][Full Text] [Related]
40. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.
Campbell S; Vogt VM
J Virol; 1995 Oct; 69(10):6487-97. PubMed ID: 7666550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
